Cargando…

Antibiotic resistance: A disregarded concern for misuse of azithromycin in COVID-19 treatment

Detalles Bibliográficos
Autores principales:	Jahanshahlou, Farid, Hosseini, Mohammad-Salar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607170/ https://www.ncbi.nlm.nih.gov/pubmed/34899939 http://dx.doi.org/10.4103/jrms.JRMS_1124_20

Ejemplares similares

Persisting on Readability Could Provoke the Risk of Misinformation: A COVID-19 Pandemic Concern
por: Hosseini, Mohammad-Salar, et al.
Publicado: (2021)

Comment on ‘Toxicities associated with immune checkpoint inhibitors: A systematic study’
por: Hosseini, Mohammad-Salar, et al.
Publicado: (2023)

Unrealistic Nonphysiological Amounts of Reagents and a Disregard for Published Literature
por: Ginsburg, Isaac
Publicado: (2015)

Are we misusing the ILMA tube? A cause of concern?
por: Bhalotra, Anju Romina
Publicado: (2019)

Azithromycin, a questionable treatment for COVID-19
por: Belfaqeeh, O., et al.
Publicado: (2021)

The necessity of integrating telehealth and surgical oncology practice
por: Hosseini, Mohammad-Salar, et al.
Publicado: (2023)

Kawasaki or Kawasaki-like disease? A debate on COVID-19 infection in children
por: Hosseini, Mohammad-Salar
Publicado: (2021)

Legislation Alone is Enough to Combat Antibiotic Misuse? Certainly Not!
por: Barah, F, et al.
Publicado: (2014)

Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Azithromycin in patients with COVID-19: Friend or foe?
por: Kow, Chia Siang, et al.
Publicado: (2021)

COVID-19 Outbreak in Iran: Lessons to Learn, Measures to Take
por: Mahmoodpoor, Ata, et al.
Publicado: (2021)

Problems with the analysis in “Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19”
por: Atkinson, J. Graham
Publicado: (2020)

Use of Azithromycin in COVID-19: A Cautionary Tale
por: Kow, Chia Siang, et al.
Publicado: (2020)

Alcohol Misuse May Increase the Severity of COVID-19 Infections
por: Abbasi-Oshaghi, Ebrahim, et al.
Publicado: (2020)

Postesophagectomy chylothorax: a review of the risk factors, diagnosis, and management
por: Zarei, Mahdi, et al.
Publicado: (2023)

Benzodiazepines Misuse
por: Wiwanitkit, Viroj
Publicado: (2011)

Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Substance misuse during COVID-19: protecting people who use drugs
por: Armitage, R., et al.
Publicado: (2020)

Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients
por: Lacout, Alexis, et al.
Publicado: (2021)

Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response
por: Fiolet, Thibault, et al.
Publicado: (2021)

Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature
por: Goldman, Jason D., et al.
Publicado: (2021)

Misinformation in Wake of the COVID-19 Outbreak: Fueling Shortage and Misuse of Lifesaving Drugs in Pakistan
por: Hashmi, Furqan Khurshid, et al.
Publicado: (2020)

The overshadowed opioid misuse pandemic
por: Cohen, Shaul, et al.
Publicado: (2022)

Risk of QTc prolongation with Chloroquine/Hyroxychloroquine and Azithromycin treatment for COVID‐19: Quantification and precautions for a busy clinician
por: Mansuri, Zeeshan, et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

Professional Etiquette Disregarded in India
Publicado: (1866)

Shigella flexneri with Ciprofloxacin Resistance and Reduced Azithromycin Susceptibility, Canada, 2015
por: Gaudreau, Christiane, et al.
Publicado: (2016)

Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response
por: Fiolet, Thibault, et al.
Publicado: (2021)

Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend
por: Hor, Chee Peng, et al.
Publicado: (2020)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

Efflux Pump Antibiotic Binding Site Mutations Are Associated with Azithromycin Nonsusceptibility in Clinical Neisseria gonorrhoeae Isolates
por: Ma, Kevin C., et al.
Publicado: (2020)

Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial
por: dos Santos, Marcelo Rodrigues
Publicado: (2021)

Response to the editorial “COVID-19 in patients with cardiovascular diseases”: Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Lacout, Alexis, et al.
Publicado: (2021)

COVID‐19 and (hydroxy)chloroquine–azithromycin combination: Should we take the risk for our patients?
por: Javelot, Hervé, et al.
Publicado: (2020)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Azithromycin Misuse During the COVID-19 Pandemic: A Cross-Sectional Study from Jordan
por: Abdelmalek, Suzanne M A, et al.
Publicado: (2022)

Letter to the editor about “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”
por: Saad, Mohamed O
Publicado: (2021)

Focus on clinical outcomes of “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”
por: Wambier, Carlos Gustavo
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v4v1gf42ls0k23hm04cmsf79qd